120 related articles for article (PubMed ID: 23271214)
1. Successful treatment of secondary NK/T-cell lymphoma of the testis.
Kobayashi T; Hangaishi A; Yamamoto G; Shinohara A; Morikawa T; Takazawa Y; Ota S; Imai Y; Nakamura F; Kurokawa M
Ann Hematol; 2013 Jul; 92(7):997-8. PubMed ID: 23271214
[No Abstract] [Full Text] [Related]
2. [Treatment of localized nasal NK/T-cell lymphoma].
Yamaguchi M
Rinsho Ketsueki; 2008 Aug; 49(8):553-8. PubMed ID: 18800601
[No Abstract] [Full Text] [Related]
3. Extranodal NK/T cell lymphoma, nasal type, presenting with meningeal infiltration in a Caucasian female.
Hildyard C; Sheikh S; Eyre T; Collins G
Br J Haematol; 2013 Dec; 163(5):550. PubMed ID: 24033120
[No Abstract] [Full Text] [Related]
4. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.
Kim SJ; Kim K; Kim BS; Kim CY; Suh C; Huh J; Lee SW; Kim JS; Cho J; Lee GW; Kang KM; Eom HS; Pyo HR; Ahn YC; Ko YH; Kim WS
J Clin Oncol; 2009 Dec; 27(35):6027-32. PubMed ID: 19884539
[TBL] [Abstract][Full Text] [Related]
5. [Concurrent chemoradiotherapy for localized nasal NK/T-cell lymphoma].
Yamaguchi M
Rinsho Ketsueki; 2010 Jul; 51(7):500-7. PubMed ID: 20693769
[No Abstract] [Full Text] [Related]
6. [Long-term remission of a nasal NK/T-cell lymphoma patient with massive involvement of the orbita and liver dysfunction].
Monma F; Ueno S; Yamaguchi M; Tawara I; Miyazaki K; Nishii K; Nakase K; Katayama N
Rinsho Ketsueki; 2009 Jan; 50(1):44-8. PubMed ID: 19225229
[TBL] [Abstract][Full Text] [Related]
7. Successful full-dose DeVIC therapy in a patient with advanced-stage extranodal natural killer/T-cell lymphoma refractory to L-asparaginase.
Watanabe J; Makita S; Ito Y; Hatta S; Suzuki T; Yuda S; Maeshima AM; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Kim SW; Izutsu K
Ann Hematol; 2018 Sep; 97(9):1739-1740. PubMed ID: 29663028
[No Abstract] [Full Text] [Related]
8. Successful treatment of extranodal natural killer/T-cell lymphoma, nasal type, complicated by severe hemophagocytic syndrome, with dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide chemotherapy followed by autologous stem cell transplant.
Inoue D; Nagai Y; Takiuchi Y; Nagano S; Arima H; Kimura T; Shimoji S; Mori M; Togami K; Tabata S; Yanagita S; Matsushita A; Nagai K; Maruoka H; Imai Y; Suzuki R; Takahashi T
Leuk Lymphoma; 2010 Apr; 51(4):720-3. PubMed ID: 20233057
[No Abstract] [Full Text] [Related]
9. Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.
Yamaguchi M; Tobinai K; Oguchi M; Ishizuka N; Kobayashi Y; Isobe Y; Ishizawa K; Maseki N; Itoh K; Usui N; Wasada I; Kinoshita T; Ohshima K; Matsuno Y; Terauchi T; Nawano S; Ishikura S; Kagami Y; Hotta T; Oshimi K
J Clin Oncol; 2009 Nov; 27(33):5594-600. PubMed ID: 19805668
[TBL] [Abstract][Full Text] [Related]
10. Pediatric nasal NK/T-cell lymphoma microscopically mimicking carcinoma.
Sánchez-Romero C; Paes de Almeida O; Díaz Molina JP; Carlos R
Int J Dermatol; 2020 Mar; 59(3):373-376. PubMed ID: 31729756
[No Abstract] [Full Text] [Related]
11. The ICE regimen (ifosfamide, carboplatin, etoposide) for the treatment of germ-cell tumors and metastatic trophoblastic disease.
Lotz JP; André T; Bouleuc C; Péne F; Gattegno B; Bazelly B; Houry S; Chapiro J; Selle F; Gligorov J; Izrael V
Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S55-9. PubMed ID: 8899175
[No Abstract] [Full Text] [Related]
12. Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience.
Hara I; Miyake H; Yamada Y; Yamanaka K; Furukawa J; Kumano M; Takenaka A; Fujisawa M
Anticancer Drugs; 2006 Oct; 17(9):1057-66. PubMed ID: 17001179
[TBL] [Abstract][Full Text] [Related]
13. Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.
Abali H; Urün Y; Oksüzoğlu B; Budakoğlu B; Yildirim N; Güler T; Ozet G; Zengin N
Cancer Invest; 2008 May; 26(4):401-6. PubMed ID: 18443961
[TBL] [Abstract][Full Text] [Related]
14. Sequential intermediate high-dose chemotherapy in the primary treatment of poor risk testicular cancer.
Schmoll HJ; Bokemeyer C
Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S48-9. PubMed ID: 8899172
[No Abstract] [Full Text] [Related]
15. Contralateral testicular relapse after prophylactic radiation in a patient with primary testicular diffuse large B-cell lymphoma.
Conrad AL; Go RS
Eur J Haematol; 2009 Dec; 83(6):603-5. PubMed ID: 19682312
[TBL] [Abstract][Full Text] [Related]
16. [Tumour markers--case report].
Lamerz R; Stieber P
Dtsch Med Wochenschr; 2004 Dec; 129(50):2721. PubMed ID: 15592973
[No Abstract] [Full Text] [Related]
17. [Effectiveness of DeVIC chemotherapy for recurrent primary central nervous system lymphoma].
Takasu S; Wakabayashi T; Kajita Y; Hatano N; Hatano H; Usui T; Kinoshita T; Yoshida J
No Shinkei Geka; 2000 Sep; 28(9):789-94. PubMed ID: 11025878
[TBL] [Abstract][Full Text] [Related]
18. Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
Chang AY; Boros L; Garrow GC; Asbury RF; Hui L
Semin Oncol; 1996 Jun; 23(3 Suppl 6):74-7. PubMed ID: 8677454
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of brainstem involvement in NK/T cell lymphoma.
So JC; Chan KH; Pang AW; Chan JK; Kwong YL
Ann Hematol; 2014 Aug; 93(8):1433-4. PubMed ID: 24292537
[No Abstract] [Full Text] [Related]
[Next] [New Search]
